Stay updated on Regeneron Press Releases
Sign up to get notified when there's something new on the Regeneron Press Releases page.

Latest updates to the Regeneron Press Releases page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe web page has added a new section or content labeled 'Page 3'.SummaryDifference0.6%
- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedThe page now includes the approval of Dupixent® as the first biologic medicine for COPD in Japan, while the previous announcement regarding EYLEA HD®'s positive Phase 3 results has been removed.SummaryDifference17%
- Check53 days agoChange DetectedThe page has been updated to include information about the Regeneron Science Talent Search 2025 Awards, which offers over $1.8 million to high school seniors for innovative scientific research. The previous financial report regarding Regeneron's fourth quarter and full year 2024 results has been removed.SummaryDifference23%
- Check60 days agoChange DetectedThe page has added information about a late-breaking presentation of pivotal data for Dupixent® in relation to Bullous Pemphigoid, while it has removed details about a competition for high school scientists with significant awards.SummaryDifference14%
- Check74 days agoChange DetectedThe web page has added pagination controls, allowing users to navigate between multiple pages of content more easily.SummaryDifference3%
- Check81 days agoChange DetectedThe webpage has added significant announcements regarding Regeneron's investor conference presentations and the acceptance of Linvoseltamab's BLA for FDA review, which are crucial updates in the context of pharmaceutical developments.SummaryDifference11%
Stay in the know with updates to Regeneron Press Releases
Enter your email address, and we'll notify you when there's something new on the Regeneron Press Releases page.